Expansion Into China's Lower-Tier Cities Could Be Growth Driver For Big Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
China's smaller cities are emerging rapidly as growth areas, while Big Pharma is still focused mostly on Tier 1 cities such as Shanghai, Beijing and Guangzhou, according to IMS Health.